May 9 (Reuters)-
GL Sciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2018 Mar 31, 2017 Mar 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 22.94 20.58 24.16 11.52
(+11.4 pct) (+11.3 pct) (+5.3 pct) (+6.5 pct)
Operating 2.42 1.80 2.15 856 mln
(+34.3 pct) (+88.6 pct) (-11.1 pct) (-20.9 pct)
Recurring 2.56 2.06 2.19 891 mln
(+24.2 pct) (+88.0 pct) (-14.5 pct) (-25.6 pct)
Net
Net 1.75 1.32 1.31 507 mln
(+32.5 pct) (+70.4 pct) (-24.7 pct) (-34.4 pct)
EPS 170.28 yen 128.52 yen 128.15 yen 49.43 yen
Ann Div 30.00 yen 27.00 yen 30.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 30.00 yen 27.00 yen 30.00 yen
NOTE - GL Sciences Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7705.T